北京商报讯（记者 胡永新）8月27日晚间，中国人寿保险股份有限公司（以下简称"中国人寿"）发布 2025年半年度报告。报告显示，中国人寿中期现金分红达67.27亿元。这是该公司连续第2年保持中期、 年度两次分红频次。在稳健发展的同时，该公司积极响应"提质增效重回报"专项行动，与投资者共享高 质量发展成果，自上市以来，已累计分红约2277亿元。 ...

北京商报讯（记者 胡永新）8月27日晚间，中国人寿保险股份有限公司（以下简称"中国人寿"）发布 2025年半年度报告。2025年上半年，该公司总保费达5250.88亿元，创历史同期最好水平，同比增长 7.3%，市场份额稳步提升。 此外，中国人寿持续深化资产负债联动，2025年上半年，该公司实现归属于母公司股东的净利润为 409.31亿元，同比增长6.9%。注重增强投资者回报水平和获得感，该公司积极响应"提质增效重回报"专 项行动，与投资者共享高质量发展成果，董事会建议派发2025年中期现金股息每10股2.38元（含税）， 中期现金分红达67.27亿元。 ...

Core Points - The board of directors of Guodian NARI Technology Co., Ltd. held its seventh meeting of the ninth session on August 15, 2025, and made several important resolutions [1][2][3] Group 1: Fund Management and Financial Reports - The board approved the special report on the use and storage of raised funds for the first half of 2025 with unanimous consent [1] - The board approved the use of part of the idle raised funds for cash management and temporary replenishment of working capital, also with unanimous consent [2] - The board approved the profit distribution plan for the first half of 2025, again with unanimous consent [2][5] Group 2: Risk Assessment and Credit Facilities - The board reviewed and approved the risk assessment report for financial business conducted with China Electric Power Finance Co., Ltd., with specific directors abstaining from voting [3][4] - The company is authorized to apply for a comprehensive credit limit not exceeding RMB 31 billion from various banks, with specific allocations detailed for each bank [4] Group 3: Operational and Management Reports - The board approved the half-year report and summary for 2025, confirming the accuracy and completeness of the financial report [5] - The board approved the half-year evaluation report of the "Quality Improvement and Efficiency Enhancement" action plan for 2025 [5] - The board approved the revision of the "Company Authorization Management Measures" [5]

证券代码：603661 证券简称：恒林股份 公告编号：2025-031 恒林家居股份有限公司 第七届董事会第七次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 恒林家居股份有限公司（以下简称公司）第七届董事会第七次会议于 2025 年 8 月 27 日在浙江省湖州市安吉县递铺街道恒林 B 区办公楼 107 会议室以现场 结合通讯方式召开，会议通知已按规定提前以书面及通讯方式送达。本次会议 由董事长王江林先生召集并主持，会议应出席董事 7 名，实际出席董事 7 名， 公司高级管理人员全部列席了本次会议。本次会议的召集、召开及表决程序符 合《中华人民共和国公司法》和《恒林家居股份有限公司章程》等相关规定， 会议形成的决议合法、有效。 二、董事会会议审议情况 （一）审议通过《公司 2025 年半年度报告及其摘要》 经审议，董事会认为公司编制的《恒林股份 2025 年半年度报告》及其摘要 符合法律、行政法规、中国证监会和上海证券交易所的相关规定，报告内容真 实、准确、完整地反映了公司 2025 年 ...

Meeting Overview - The fifth meeting of the fifth board of directors of Hefei Changqing Machinery Co., Ltd. was held, with all seven directors present, and the meeting was deemed legal and effective [1]. Resolutions Passed - The board approved the 2025 semi-annual report and its summary, which had been reviewed by the audit committee [1]. - The board approved the special report on the storage and actual use of raised funds for the first half of 2025 [2]. - The board approved the use of part of the idle raised funds for cash management [2]. - The board approved the proposal to cancel the supervisory board and amend the company’s articles of association, which will require approval at the shareholders' meeting [2][3]. - The board approved amendments and formulations of certain governance systems to align with the revised articles of association [2][3]. - The board approved the semi-annual evaluation report on the "Quality Improvement and Efficiency Enhancement Return" action plan for 2025, which aims to optimize operations and improve governance [7]. - The board approved the proposal to supplement a non-independent director, which will also require shareholder approval [8]. - The board approved the proposal to convene the first temporary shareholders' meeting of 2025 [8].

Core Viewpoint - The company is actively implementing the "Quality Improvement and Efficiency Enhancement" initiative, focusing on enhancing core capabilities, expanding market presence, and improving product quality while maintaining a commitment to shareholder interests and social responsibility [1][2][3]. Group 1: Strengthening Core Capabilities - The company has focused on the special protection field, achieving significant order fulfillment exceeding annual budget in the first half of 2025 [1]. - The company participated in four bidding processes for special products and successfully secured contracts, ensuring timely delivery [1]. - A new quality management system is being established, with training and process design completed [1]. Group 2: Civil Product Development - New product sales, such as pen-type injector components, have significantly increased, leading to a 3.48 percentage point rise in gross margin for civil products [2]. - The company has signed strategic cooperation agreements with new clients and expanded foreign trade channels, resulting in a 5% year-on-year increase in exports [2]. - The company successfully activated the registration number for a new insulin pen component, achieving important regulatory approval [2]. Group 3: Technological Innovation - Research and development investment reached 16.3% of revenue, a 4.65 percentage point increase year-on-year [2]. - The company has applied for 20 patents, including 15 invention patents, and achieved a 91.94% completion rate for research project milestones [2]. - An innovation platform is being established, centered around a national-level enterprise technology center [2]. Group 4: Quality and Efficiency Improvement - The company has implemented 86 specific measures to enhance quality and efficiency, focusing on cost reduction and revenue increase [3]. - A total of 6,715 million yuan was generated in additional revenue through various initiatives in the first half of 2025 [3]. - The company achieved a comprehensive cost reduction of 15.27 million yuan [3]. Group 5: Reform and Development - The company has completed 93% of its planned 100 reform tasks, receiving high marks in reform assessments [4]. - The brand strength increased by 7% to 892, maintaining its position on the Chinese brand value evaluation list [4]. - Digital transformation initiatives are underway, including the intelligent transformation of production facilities [4]. Group 6: Corporate Governance - The company has established a modern corporate governance system, implementing new management and compliance policies [6]. - A total of 68 announcements were made in the first half of 2025, including annual and quarterly reports [7]. - The company’s ESG rating improved from "BB" to "A," reflecting excellence in environmental, social, and governance practices [7]. Group 7: Investor Relations - The company has enhanced communication with investors, holding performance briefings and engaging in various outreach activities [8]. - A cash dividend of 0.434 yuan per share was distributed, representing 90.07% of the net profit attributable to shareholders [8]. - The company has established a value management system to comply with regulatory requirements and improve market performance [9]. Group 8: Management Responsibility - The company emphasizes the responsibility of key personnel, enhancing their awareness of compliance and operational standards [10]. - Training sessions for management and key personnel have been conducted to improve their capabilities [10]. Group 9: Future Outlook - The company will continue to evaluate the implementation of the "Quality Improvement and Efficiency Enhancement" initiative and maintain transparency in its operations [11].

证券代码：688507 证券简称：索辰科技 公告编号：2025-043 上海索辰信息科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 上海索辰信息科技股份有限公司（简称"公司"）第二届董事会第十八次会议 于 2025 年 8 月 27 日在公司会议室以现场结合通讯方式召开，会议通知已于 2025 年 8 月 26 日以书面方式送达各位董事。会议由公司董事长陈灏先生主持，应参会 董事 7 名，实际参会董事 7 名。董事长陈灏先生于本次董事会会议上就紧急会议的 原因进行了说明。会议的召集、召开和表决情况符合《中华人民共和国公司法》等 有关法律、法规及《上海索辰信息科技股份有限公司章程》（简称《公司章程》） 的规定，形成的决议合法、有效。 具体内容详见公司同日刊登于上海证券交易所网站（www.sse.com.cn）的《关 于公司 2025 年度"提质增效重回报"专项行动方案的半年度评估报告的公告》。 （二）审议通过了《关于 <公司 ensp="ensp" 年半年度报告="年半年度报告"> ...

Group 1 - The board of directors of Kebo Da Technology Co., Ltd. held its 18th meeting of the third session on August 26, 2025, with all 9 directors present, ensuring compliance with relevant laws and regulations [1][2]. - The board approved the 2025 semi-annual report and its summary, which had been reviewed by the audit committee [2]. - The board also approved the "Quality Improvement and Efficiency Enhancement Action Plan for 2025," aimed at enhancing company quality and shareholder returns in response to regulatory requirements [2][3]. Group 2 - The board passed a resolution to establish a "Market Value Management System" to standardize market value management practices and protect the rights of investors, particularly small and medium-sized investors [2][3].

Group 1 - The board of directors of Shanghai Weisaibo New Materials Co., Ltd. held its 23rd meeting of the 5th board, with all 6 directors present, confirming the legality and validity of the meeting procedures [1][2] - The board approved the semi-annual report for 2025 and its summary, which had been reviewed by the audit committee prior to the meeting [1][2] - The board also approved the semi-annual evaluation report of the "Quality Improvement and Efficiency Enhancement Return" action plan for 2025 [2] - A profit distribution plan for the first half of 2025 was approved, pending further review by the first extraordinary shareholders' meeting of 2025 [2][3] - The board proposed to hold the first extraordinary shareholders' meeting of 2025 on September 15, 2025, in accordance with the company's articles of association [3]

证券代码：601877 证券简称：正泰电器 公告编号：临 2025-047 浙江正泰电器股份有限公司 第十届董事会第五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江正泰电器股份有限公司（以下简称"公司"）第十届董事会第五次会议于 2025 年 华人民共和国公司法》及《浙江正泰电器股份有限公司章程》的规定，本次会议合法有效。 经表决通过了以下议案： 一、审议通过《关于公司 2025 年半年度报告及摘要的议案》 会议以 9 票同意，0 票反对，0 票弃权，审议通过了《关于公司 2025 年半年度报告及摘 要的议案》，同意公司 2025 年半年度报告及摘要内容。 公司董事会审计委员会事前已审议通过本议案，并同意提交董事会审议。 具体内容详见公司同日发布于上海证券交易所网站（www.sse.com.cn）的《2025 年半年 度报告》及摘要。 会议以 3 票同意，0 票反对，0 票弃权，审议通过了《关于正泰集团财务有限公司 2025 年半年度风险持续评估报告的议案》，关联董事南存辉、朱信敏、陈国良、陆川、南尔、林 ...